B2B ad examples

With the right investments, the Rural Health Transformation Program drives lasting impact.

CMS now expects continuous, risk-based provider oversight. Is your Medicaid program ready?

If your fibroblasts are already activated before you even start, your mechanistic study is over. 2D plastic drives uncontrolled activation. The Fibroblast Activation Validated Solution keeps fibroblasts in a clean, activatable baseline in 3D, so your TGF-β response is the signal, not the noise.

Join us on November 10, 2026, for the third webinar in our free series: The value of Automation – Practical application insights for smarter labs In this session we'll explore: Modern Nucleic Acid Purification – Automation for Improved Efficiency High-quality nucleic acid purification is a crucial first step in molecular biology, cell therapy, and gene therapy workflows. As laboratories handle increasing demands for throughput, reproducibility, and standardization, automation can help improve sample preparation processes. Join us for a practical webinar with Dr. Laura Herold, Product Manager at Macherey-Nagel, who specializes in nucleic acid purification workflows and their automation. Together, we’ll explore automated solutions for DNA and RNA purification, review key purification technologies, and look at important applications on our epMotion platforms. You’ll also learn about the strengths and limitations of different processing approaches and how automation can support productivity, consistency, and scalability. Why attend? • Understand the key principles behind automated DNA and RNA purification. • Explore different purification technologies and their applications. • Learn how automated workflows can reduce manual intervention. • Discover how automation can support reproducibility and process consistency. • Consider where automation can add value in your laboratory. • Gain practical insights into nucleic acid purification on epMotion platforms. Leave with a clearer view of how automated purification workflows can support reliable, scalable sample preparation. Join us and explore the next step toward more efficient nucleic acid purification. 📅 November 10, 2026 | 4:00 p.m. CET Join us live and bring your questions about laboratory automation.

L’edizione di quest’anno del Barometro della resilienza sanitaria classifica la resilienza dei sistemi sanitari di 42 Paesi attraverso quattro aree chiave: sicurezza del paziente, forza lavoro, sostenibilità ambientale ed efficienza. In ogni nuova edizione, il Barometro supporta leader e decisori del settore a rafforzare le performance dei sistemi in contesti di crescente pressione, aiutandoli a confrontare i propri risultati, individuare vulnerabilità poco evidenti e definire con maggiore consapevolezza le priorità di intervento. Scarica il report completo per approfondire i risultati.

🧬 A complementary approach for advanced solid tumors The greatest potential for WEE1 and PKMYT1 inhibition lies in cancers marked by high replication stress and genomic instability, where late cell-cycle checkpoints become critical for survival. This includes advanced solid tumors with specific molecular vulnerabilities, such as alterations that drive uncontrolled cell-cycle progression and checkpoint dependence. Tumor types where these features are commonly observed include: ovarian, breast, lung, colorectal, gastric, and pancreatic cancers, among others. By aligning therapy with underlying biology, this combination strategy aims to focus treatment where it is most likely to be effective. 👇 Learn more about our ongoing clinical trial https://lnkd.in/dfAtKP2M #DNADamageResponse #DDR #PKMYT1 #WEE1 #Oncology #ClinicalTrial #Debiopharm

Η καρδιακή ανεπάρκεια μπορεί να εξηγεί πολλά συμπτώματα. Τι συμβαίνει όμως όταν η αιτία της δεν είναι ξεκάθαρη; 💚 Σε ορισμένες περιπτώσεις, ενδείξεις όπως το σύνδρομο καρπιαίου σωλήνα ή η οσφυϊκή σπονδυλική στένωση μπορεί να συνδέονται με την ATTR-CM, μια καρδιακή πάθηση που δεν είναι πάντα εύκολο να αναγνωριστεί. Γνωρίζατε ότι τα άτομα με μυοκαρδιοπάθεια από αμυλοείδωση τρανσθυρετίνης (ATTR-CM) έχουν, κατά μέσο όρο, 17 επισκέψεις σε νοσοκομειακές δομές* μέχρι να λάβουν τη σωστή διάγνωση; Με αφορμή την Παγκόσμια Ημέρα Αμυλοείδωσης, ας κοιτάξουμε πέρα από την πρώτη εξήγηση. Γιατί κάθε ένδειξη μπορεί να έχει σημασία. 🔗 Μάθε περισσότερα: https://pharma.bayer.gr/ *Παραπομπή: Lane T, et al. Circulation. 2019 Jul 2;140(1):16-26. #BayerHellas #WorldAmyloidosisDay #ATTRCM #LookAgain COR-PF-CAR-GR-0005-1

Join us on November 12, 2026, for the fourth webinar in our free series: The value of automation - Practical insights for smarter labs In this session, we’ll explore: Opportunities and applications for next-generation sequencing technologies Next-generation sequencing has changed how scientists explore biological questions. Advances in sequencing technology have improved throughput, accuracy, and read lengths, while making sequencing more accessible across a growing range of applications. Join us for a practical webinar with Karen McKay, Senior Development Associate at New England Biolabs. Karen brings extensive experience in sequencing library preparation and product development. Since joining NEB in 2015, she has contributed to the development of several NEBNext® products and regularly supports customers through hands-on training. Together, we’ll explore how next-generation sequencing is being used in genomics, transcriptomics, epigenomics, metagenomics, and more. We’ll also look at why laboratories are turning to automation to support the scale, consistency, and reproducibility required for sequencing library preparation. Why attend? • Build a clear understanding of how next-generation sequencing technologies have developed. • Explore current and emerging applications across a range of scientific fields. • Learn why sequencing workflows increasingly require scalable and reproducible sample processing. • Discover how automation can support high-throughput library preparation. • Consider which steps in your workflow may be well suited to automation. • Gain practical insights into transferring manual library preparation protocols to an automated platform. Leave with a clearer view of how next-generation sequencing and automation can work together to support reliable, scalable workflows. Join us live and bring your questions about sequencing and laboratory automation. 📅 November 12, 2026 | 4:00 p.m. CET Join us live and bring your questions about laboratory automation.

Préparer les systèmes de santé aux défis de demain Pressions sur les ressources, évolution de la demande, nouveaux risques : le Baromètre BD identifie les leviers clés pour renforcer durablement la résilience des systèmes de santé.

Year-end has a way of arriving quickly. And as research teams put remaining budgets to work, demand for disease-state biospecimens can ramp up too. BioIVT has been building inventory to support research needs now and into 2027, including: • Disease- and normal-state CSF • Serum, plasma, and other blood-derived biofluids • Ethically sourced clinical tissues 𝗞𝗻𝗼𝘄 𝘄𝗵𝗮𝘁 𝘆𝗼𝘂’𝗹𝗹 𝗻𝗲𝗲𝗱? 𝗗𝗼𝗻’𝘁 𝘄𝗮𝗶𝘁 𝗳𝗼𝗿 𝘁𝗵𝗲 𝘆𝗲𝗮𝗿-𝗲𝗻𝗱 𝗿𝘂𝘀𝗵. Plan now while availability is strong. https://hubs.ly/Q04z8Rmv0

Um exame de imagem também pode ajudar a conhecer características do câncer de mama. Algumas células tumorais possuem receptores de estrogênio, proteínas às quais esse hormônio pode se ligar e estimular o crescimento dessas células. O 18F-FES é uma substância produzida pela CMR e que é usada em exames de medicina nuclear que funciona como um marcador. Ele se liga aos receptores de estrogênio e emite um sinal identificado pelo PET/CT, permitindo avaliar sua presença em diferentes lesões. Essa informação ajuda a equipe médica a compreender melhor a doença e pode contribuir para a escolha do tratamento. O exame tem indicações específicas e complementa outros resultados, sem substituir a biópsia quando necessária. Salve para consultar depois e compartilhe com alguém que queira entender melhor esse exame. #CMRPharma #OutubroRosa #MedicinaNuclear #CâncerDeMama VENDA SOB PRESCRIÇÃO. SE PERSISTIREM OS SINTOMAS, O MÉDICO DEVERÁ SER CONSULTADO. Contraindicações, advertências, reações adversas, interações medicamentosas, precauções e posologia: consulte a Ficha Técnica destinada ao Profissional de Saúde. Ofício de Notificação do FES-¹⁸F: 0137807244.

Potency, purity, taste, and transparency. Omega-3 innovation comes with complex challenges. Discover a new approach that starts with microalgae.

Support can mean meeting people where they are as they navigate their relationship with opioids, with care that adapts to their needs over time.

For HCPs in the UK and Ireland only. This post has been developed in collaboration with, and funded by, Boehringer Ingelheim. References available via the linked resource below. We wouldn't do a cardiovascular disease review without a blood pressure reading. So why do we do them without a uACR? Sometimes we come across data so stark that it makes you stop and think – how can we do better in our clinical practice? 66% of adults with recorded hypertension in England did not receive a uACR test in the last 12 months preceding December 2025 [Data extracted from CVDPrevent; accessed at: https://lnkd.in/di3xrbEy]. CKD isn't just a kidney problem, it is a cardiovascular problem! People with CKD are 6x more likely to experience a major cardiovascular event and are more likely to die from a heart attack or stroke than ever reaching end-stage renal disease (Based on Greater Manchester data) [Boehringer Ingelheim. Data on file. CRM 2-131025]. Albuminuria, measured by a urine ACR test, is an independent cardiovascular risk marker. Even modest rises can be associated with dramatically higher CV risk, including a 69% increased risk of CV disease [Xia et al, Int J Clin Exp Med 2015]. And it can signal damage to the structure of the kidneys way before eGFR has moved at all. The uACR test is simple. It's cheap and it requires little more than the right bottle to collect it in. When interpreted alongside clinical assessment, eGFR and other established cardiovascular risk factors, uACR identifies people with or at risk of kidney damage earlier, enables better risk stratification, and informs timely use of evidence-based therapies that can slow progression and reduce CV risk in accordance with current clinical guidance. Yet, despite all our guidelines recommending testing, the majority of patients with hypertension are being missed, meaning we can’t know for sure just how high their cardiovascular risk is… We can do better. uACR should be part of every cardiovascular review. 👇 Watch the video and click on the link below for more. And if this resonates, share it. Let's get the word out there and let’s get testing. https://lnkd.in/dc-pFrWg NP-GB-107940 v2 | October 2026

El Niño has exposed the vulnerability of marine omega-3 supply. Could microalgae offer a new way forward? Find out now.

API China will gather the pharmaceutical industry in Wuhan from 11 to 13 November, and the Flarer team can’t miss the chance to be there. Alex Bolognini and Ermanno Germani are ready. And you? #WeAreActive #Flarer #APIChina

On 23 December, the Farmak brand marks 100 years. A milestone built over decades, shaped by experience and carried forward through everyday work. Today is a moment to pause and recognise the people behind the work — past and present. 📍 More on the 100-year story: https://lnkd.in/grmppbYu

[#RSNA2026] 🩻 Clinical imaging professionals are under growing pressure to do more amid increasing complexity and limited resources. Our infographic explores the three biggest challenges facing radiology today and how technology can help create more efficient, connected and adaptive imaging workflows. 💡Our Dedalus DeepUnity Suite is here to support you in your daily struggles, with products seamlessly integrated into your workflows. Want to learn more? Make sure to book your personalized demo at the link in bio! At RSNA you can find us at 📍 McCormick Place, Chicago 📅 November 29 – December 2 📌 Booth #1968 | South Hall, Level 3 #HealthcareIT #ConnectedDiagnostics #EnterpriseImaging #DigitalHealth

From dossier to production — one integrated system. At Farmak International, sterile injectables are managed as a continuous process: from development through to commercial supply. 🔬 Dossier development is handled internally, enabling faster adaptation to local requirements and reducing external dependencies. ⚙️ Development, scale-up, and manufacturing are aligned within one workflow, supporting smoother transitions to commercial production. 📦 Dedicated injectables capacity across formats allows more structured and predictable supply planning. 🔄 Processes are designed and maintained within the same system, ensuring consistency across batches and lifecycle stages. For partners, this means clearer ownership and more predictable timelines from registration to launch with fewer variables along the way. ▶️ See how this system works in practice: https://lnkd.in/devFp7JK

Have you seen our full lineup of RUO- and GMP-grade leukopaks? Featuring both normal and disease state donors from a diverse pool including over 600 HLA-typed recallable, consented donors near biotech hubs in the US and UK/EU. Take a look! https://lnkd.in/eGmqrd2f

At Baupharma, the greatest strength is the people. In this interview, Chief Digital Officer, Michaela Rehorovska, shares her journey with Baupharma and her perspective on what makes our multinational, multicultural team so unique. From diverse backgrounds and experiences to a shared commitment to collaboration and excellence, Baupharma’s people are at the heart of everything done. 𝗪𝗮𝘁𝗰𝗵 𝘁𝗵𝗲 𝗶𝗻𝘁𝗲𝗿𝘃𝗶𝗲𝘄 𝘁𝗼 𝗱𝗶𝘀𝗰𝗼𝘃𝗲𝗿 𝗵𝗼𝘄 𝗮 𝗴𝗹𝗼𝗯𝗮𝗹 𝘁𝗲𝗮𝗺 𝗰𝗼𝗻𝘁𝗶𝗻𝘂𝗲𝘀 𝘁𝗼 𝗱𝗿𝗶𝘃𝗲 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝘀𝘂𝗽𝗽𝗼𝗿𝘁 𝗹𝗶𝗳𝗲 𝘀𝗰𝗶𝗲𝗻𝗰𝗲𝘀 𝗼𝗿𝗴𝗮𝗻𝗶𝘇𝗮𝘁𝗶𝗼𝗻𝘀 𝗮𝗿𝗼𝘂𝗻𝗱 𝘁𝗵𝗲 𝘄𝗼𝗿𝗹𝗱 👇 #Baupharma #Leadership #TeamCulture #LifeAtBaupharma #Pharmacovigilance #LifeSciences #Healthcare

Queres fazer parte da Essity Portugal? 🌍 Estamos à procura de pessoas com vontade de crescer, aprender e pôr o seu talento ao serviço de uma equipa colaborativa e com propósito, numa empresa líder em higiene e saúde. Vê a imagem para conheceres as posições que temos em aberto neste momento. 👇 Se te revês em alguma delas, descobre todos os detalhes e dá o passo aqui: http://spkl.io/60457k3xt #EssityPortugal #QuebrarBarreirasPeloBemEstar

🌿 Ácido caftárico: um marcador polifenólico-chave da videira à fitoterapia https://lnkd.in/eszzZx6j 🔎 Esterificação do ácido caféico e do ácido tartárico, o ácido caftárico é um dos principais ácidos hidroxicinâmicos encontrados na uva (Vitis vinifera), na chicória (Cichorium intybus) e na equinácea (Echinacea purpurea). 🍇 Seja para o controle da oxidação na enologia (escurecimento dos mostos) ou para o perfilamento fitoquímico de extratos botânicos com propriedades antioxidantes, sua dosagem precisa por HPLC ou LC-MS é uma etapa indispensável. 💡 Para seus trabalhos de P&D, controles de qualidade ou análises de rotina, a confiabilidade de suas curvas de calibração depende da pureza dos seus padrões. 🔬 Precisa de um padrão analítico de referência? Na Extrasynthese, oferecemos o ácido caftárico como padrão de referência altamente caracterizado: - Pureza controlada por HPLC com Certificado de Análise completo (CoA) - Dados espectrais fornecidos (RMN, EM) - Estoque disponível para envio rápido em escala de laboratório ou piloto 🧪🪴 Explore EXTRASYNTHESE catálogo, fabricante competitivo de padrões analíticos fitoquímicos : https://lnkd.in/eRXGwUuf ✈️ 🚚 Distribuídos no Brasil pela Start BioScience : https://lnkd.in/eNbARKgS #QuimicaAnalitica #Enologia #Extrasynthese #Fitoterapia #HPLC #MateriaisDeReferencia #ExtratosBotanicos

Astellas sarà presente al 99° Congresso Nazionale della Società Italiana di Urologia, che si terrà a Riccione dal 28 al 31 ottobre. Un importante appuntamento di confronto e aggiornamento per la comunità urologica, che metterà al centro l’innovazione, la ricerca e le nuove prospettive della pratica clinica, con l’obiettivo di migliorare la qualità delle cure e la vita dei pazienti. In un contesto scientifico in continua evoluzione, come cambia la gestione del carcinoma prostatico ormono-sensibile? Noi di Astellas ne parleremo in un simposio dedicato alle più recenti evidenze scientifiche nel setting HSPC, con particolare attenzione alla corretta identificazione dei pazienti e alla tempestività delle scelte terapeutiche, elementi fondamentali per ottimizzare gli esiti clinici. Se sei un professionista sanitario e parteciperai al Congresso SIU, ti aspettiamo venerdì 30 ottobre alle 13 nella Sala Bracci del Palazzo dei Congressi di Riccione. Per tutta la durata del Congresso ci trovi agli stand #12-13-37.